- Home
- PSTL vs CCCC Comparison
PSTL vs CCCC Comparison
Compare PSTL & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- CCCC
- Stock Information
- Founded
- PSTL 2018
- CCCC 2015
- Country
- PSTL United States
- CCCC United States
- Employees
- PSTL N/A
- CCCC N/A
- Industry
- PSTL Real Estate Investment Trusts
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- PSTL Real Estate
- CCCC Health Care
- Exchange
- PSTL Nasdaq
- CCCC Nasdaq
- Market Cap
- PSTL 320.0M
- CCCC 405.6M
- IPO Year
- PSTL 2019
- CCCC 2020
- Fundamental
- Price
- PSTL $14.62
- CCCC $6.21
- Analyst Decision
- PSTL Buy
- CCCC Buy
- Analyst Count
- PSTL 2
- CCCC 6
- Target Price
- PSTL $15.75
- CCCC $10.50
- AVG Volume (30 Days)
- PSTL 67.9K
- CCCC 712.7K
- Earning Date
- PSTL 11-01-2024
- CCCC 10-30-2024
- Dividend Yield
- PSTL 6.58%
- CCCC N/A
- EPS Growth
- PSTL N/A
- CCCC N/A
- EPS
- PSTL 0.09
- CCCC N/A
- Revenue
- PSTL $68,445,000.00
- CCCC $29,378,000.00
- Revenue This Year
- PSTL N/A
- CCCC $39.70
- Revenue Next Year
- PSTL $12.21
- CCCC N/A
- P/E Ratio
- PSTL $167.49
- CCCC N/A
- Revenue Growth
- PSTL 15.46
- CCCC 83.26
- 52 Week Low
- PSTL $13.00
- CCCC $1.06
- 52 Week High
- PSTL $15.15
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- PSTL 55.79
- CCCC 53.88
- Support Level
- PSTL $14.46
- CCCC $6.02
- Resistance Level
- PSTL $14.73
- CCCC $7.14
- Average True Range (ATR)
- PSTL 0.19
- CCCC 0.37
- MACD
- PSTL 0.04
- CCCC 0.10
- Stochastic Oscillator
- PSTL 84.87
- CCCC 57.14
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.